Impairment of heart rate variability control during arsenic trioxide treatment for acute promyelocytic leukemia.
Takeshita
A
A
Uehara
A
A
Shinjo
K
K
Naito
K
K
Sahara
N
N
Yamazaki
K
K
Katoh
H
H
Kamikawa
T
T
Ohnishi
K
K
Maekawa
M
M
Hayashi
H
H
Ohno
R
R
D000970:Antineoplastic Agents / Q000009:adverse effects*; D000077237:Arsenic Trioxide; D001152:Arsenicals / Q000009:adverse effects*; D006339:Heart Rate / Q000187:drug effects*; D006801:Humans; D015473:Leukemia, Promyelocytic, Acute / Q000188:drug therapy*; D010087:Oxides / Q000009:adverse effects*
D000970:Antineoplastic Agents; D001152:Arsenicals; D010087:Oxides; D000077237:Arsenic Trioxide